• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质体:一种通过血脑屏障进行天然药物递送的有前景的纳米载体。

Niosome: A Promising Nanocarrier for Natural Drug Delivery through Blood-Brain Barrier.

作者信息

Gharbavi Mahmoud, Amani Jafar, Kheiri-Manjili Hamidreza, Danafar Hossein, Sharafi Ali

机构信息

School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran.

Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.

出版信息

Adv Pharmacol Sci. 2018 Dec 11;2018:6847971. doi: 10.1155/2018/6847971. eCollection 2018.

DOI:10.1155/2018/6847971
PMID:30651728
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6311792/
Abstract

Niosomes (the nonionic surfactant vesicles), considered as novel drug delivery systems, can improve the solubility and stability of natural pharmaceutical molecules. They are established to provide targeting and controlled release of natural pharmaceutical compounds. Many factors can influence on niosome construction such as the preparation method, type and amount of surfactant, drug entrapment, temperature of lipids hydration, and the packing factor. The present review discusses about the most important features of niosomes such as their diverse structures, the different preparation approaches, characterization techniques, factors that affect their stability, their use by various routes of administration, their therapeutic applications in comparison with natural drugs, and specially the brain targeting with niosomes-ligand conjugation. It also provides recent data about the various types of ligand agents which make available active targeting drug delivery to the central neuron system. This system has an optimistic upcoming in pharmaceutical uses, mostly with the improving availability of innovative schemes to overcome blood-brain barrier and targeting the niosomes to the brain.

摘要

非离子表面活性剂囊泡(脂质体)被认为是新型药物递送系统,可提高天然药物分子的溶解度和稳定性。它们能够实现天然药物化合物的靶向递送和控释。许多因素会影响脂质体的构建,如制备方法、表面活性剂的类型和用量、药物包封、脂质水化温度以及堆积系数。本综述讨论了脂质体的最重要特征,如它们的多样结构、不同的制备方法、表征技术、影响其稳定性的因素、通过各种给药途径的应用、与天然药物相比的治疗应用,特别是脂质体 - 配体偶联的脑靶向作用。它还提供了有关各种配体试剂的最新数据,这些配体可实现向中枢神经系统的主动靶向药物递送。该系统在药物应用方面前景乐观,尤其是随着克服血脑屏障和使脂质体靶向大脑的创新方案的不断涌现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34d5/6311792/3ff51671f07e/APS2018-6847971.012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34d5/6311792/da450e04e08c/APS2018-6847971.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34d5/6311792/7e0875a63d31/APS2018-6847971.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34d5/6311792/a77f0f1b5952/APS2018-6847971.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34d5/6311792/2b26e209fcf8/APS2018-6847971.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34d5/6311792/269f0de91200/APS2018-6847971.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34d5/6311792/236baf3f3899/APS2018-6847971.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34d5/6311792/ffc2de79d07e/APS2018-6847971.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34d5/6311792/fa2b9cd8bd16/APS2018-6847971.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34d5/6311792/dbb086cb2bbd/APS2018-6847971.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34d5/6311792/64db46ab313d/APS2018-6847971.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34d5/6311792/ebeca58c6e78/APS2018-6847971.011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34d5/6311792/3ff51671f07e/APS2018-6847971.012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34d5/6311792/da450e04e08c/APS2018-6847971.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34d5/6311792/7e0875a63d31/APS2018-6847971.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34d5/6311792/a77f0f1b5952/APS2018-6847971.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34d5/6311792/2b26e209fcf8/APS2018-6847971.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34d5/6311792/269f0de91200/APS2018-6847971.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34d5/6311792/236baf3f3899/APS2018-6847971.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34d5/6311792/ffc2de79d07e/APS2018-6847971.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34d5/6311792/fa2b9cd8bd16/APS2018-6847971.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34d5/6311792/dbb086cb2bbd/APS2018-6847971.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34d5/6311792/64db46ab313d/APS2018-6847971.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34d5/6311792/ebeca58c6e78/APS2018-6847971.011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34d5/6311792/3ff51671f07e/APS2018-6847971.012.jpg

相似文献

1
Niosome: A Promising Nanocarrier for Natural Drug Delivery through Blood-Brain Barrier.脂质体:一种通过血脑屏障进行天然药物递送的有前景的纳米载体。
Adv Pharmacol Sci. 2018 Dec 11;2018:6847971. doi: 10.1155/2018/6847971. eCollection 2018.
2
Niosome as a promising tool for increasing the effectiveness of anti-inflammatory compounds.脂质体作为一种提高抗炎化合物有效性的有前景的工具。
EXCLI J. 2024 Feb 7;23:212-263. doi: 10.17179/excli2023-6868. eCollection 2024.
3
A Comprehensive Review on Niosomes as a Tool for Advanced Drug Delivery.载药囊泡作为高级药物传递工具的全面综述。
Pharm Nanotechnol. 2024;12(3):206-228. doi: 10.2174/2211738511666230726154557.
4
Recent advances in non-ionic surfactant vesicles (niosomes): Fabrication, characterization, pharmaceutical and cosmetic applications.近年来非离子表面活性剂囊泡(niosomes)的研究进展:制备、表征、药物和化妆品应用。
Eur J Pharm Biopharm. 2019 Nov;144:18-39. doi: 10.1016/j.ejpb.2019.08.015. Epub 2019 Aug 22.
5
Comprehensive Evaluation of Gene Expression in Negative and Positive Trigger-based Targeting Niosomes in HEK-293 Cell Line.基于阴性和阳性触发的靶向脂质体在HEK-293细胞系中基因表达的综合评估
Iran J Pharm Res. 2020 Winter;19(1):166-180. doi: 10.22037/ijpr.2019.112058.13507.
6
In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery.含bola-表面活性剂的囊泡用于透皮给药的体外和体内评价
Biomed Microdevices. 2007 Aug;9(4):421-33. doi: 10.1007/s10544-007-9046-6.
7
Proniosomes derived niosomes: recent advancements in drug delivery and targeting.前体脂质体衍生的尼莫体:药物传递和靶向的最新进展。
Drug Deliv. 2017;24(sup1):56-69. doi: 10.1080/10717544.2017.1384520.
8
Formulation and evaluation of niosomal nasal drug delivery system of folic acid for brain targeting.用于脑靶向的叶酸脂质体鼻给药系统的制剂与评价
Curr Drug Discov Technol. 2013 Dec;10(4):270-82. doi: 10.2174/15701638113109990031.
9
Niosomal Drug Delivery Systems for Ocular Disease-Recent Advances and Future Prospects.用于眼部疾病的脂质体药物递送系统——最新进展与未来前景
Nanomaterials (Basel). 2020 Jun 18;10(6):1191. doi: 10.3390/nano10061191.
10
Current advances in niosomes applications for drug delivery and cancer treatment.非离子表面活性剂囊泡在药物递送和癌症治疗中的应用现状进展
Mater Today Bio. 2023 Oct 21;23:100837. doi: 10.1016/j.mtbio.2023.100837. eCollection 2023 Dec.

引用本文的文献

1
Developing Immunoniosomes (INs): Antibody and Fab conjugations of niosomal nanoparticles via UV-NBS and EDC/NHS chemistry for treating glioblastoma cells.免疫非离子表面活性剂囊泡(INs)的研发:通过紫外线 - N - 溴代琥珀酰亚胺(UV - NBS)和1 - 乙基 - 3 -(3 - 二甲基氨基丙基)碳二亚胺/ N - 羟基琥珀酰亚胺(EDC / NHS)化学方法将抗体和Fab片段偶联到非离子表面活性剂囊泡纳米颗粒上用于治疗胶质母细胞瘤细胞
Int J Pharm X. 2025 Jul 23;10:100367. doi: 10.1016/j.ijpx.2025.100367. eCollection 2025 Dec.
2
The Future of Alopecia Treatment: Plant Extracts, Nanocarriers, and 3D Bioprinting in Focus.脱发治疗的未来:聚焦植物提取物、纳米载体和3D生物打印
Pharmaceutics. 2025 Apr 29;17(5):584. doi: 10.3390/pharmaceutics17050584.
3

本文引用的文献

1
Formulation of Poloxamers for Drug Delivery.用于药物递送的泊洛沙姆制剂
J Funct Biomater. 2018 Jan 18;9(1):11. doi: 10.3390/jfb9010011.
2
Targeting the Central Nervous System (CNS): A Review of Rabies Virus-Targeting Strategies.靶向中枢神经系统(CNS):狂犬病病毒靶向策略综述
Mol Pharm. 2017 Jul 3;14(7):2177-2196. doi: 10.1021/acs.molpharmaceut.7b00158. Epub 2017 Jun 16.
3
Effects of Cisplatin-Loaded Niosomal Nanoparticleson BT-20 Human Breast Carcinoma Cells.载顺铂的非离子表面活性剂囊泡纳米颗粒对BT-20人乳腺癌细胞的影响
A Comprehensive Review on Recent Advances and Patents of Niosomes.
关于非离子表面活性剂囊泡的最新进展与专利的综合综述
Recent Pat Nanotechnol. 2025;19(3):364-380. doi: 10.2174/0118722105259776231002071218.
4
PepH3-modified nanocarriers for delivery of therapeutics across the blood-brain barrier.用于跨越血脑屏障递送治疗药物的PepH3修饰纳米载体。
Fluids Barriers CNS. 2025 Apr 1;22(1):31. doi: 10.1186/s12987-025-00641-0.
5
Niosomes as Vesicular Nanocarriers in Cosmetics: Characterisation, Development and Efficacy.作为化妆品中囊泡纳米载体的非离子表面活性剂囊泡:表征、开发与功效
Pharmaceutics. 2025 Feb 21;17(3):287. doi: 10.3390/pharmaceutics17030287.
6
Magnetic Nanoparticles and Drug Delivery Systems for Anti-Cancer Applications: A Review.用于抗癌应用的磁性纳米颗粒与药物递送系统:综述
Nanomaterials (Basel). 2025 Feb 13;15(4):285. doi: 10.3390/nano15040285.
7
Formulation and characterization of BBR loaded niosomes using saponin as a nonionic biosurfactant investigating synergistic effects to enhance antibacterial activity.以皂苷作为非离子生物表面活性剂制备载有小檗碱的囊泡并进行表征,研究协同效应以增强抗菌活性。
Sci Rep. 2025 Feb 12;15(1):5231. doi: 10.1038/s41598-025-87950-4.
8
Niosome Preparation Techniques and Structure-An Illustrated Review.脂质体囊泡制备技术与结构——图文综述
Pharmaceutics. 2025 Jan 6;17(1):67. doi: 10.3390/pharmaceutics17010067.
9
Nanocarrier-mediated cancer therapy with cisplatin: .纳米载体介导的顺铂癌症治疗:
Heliyon. 2024 Mar 27;10(7):e28171. doi: 10.1016/j.heliyon.2024.e28171. eCollection 2024 Apr 15.
10
Combination Therapy of Curcumin and Cisplatin Encapsulated in Niosome Nanoparticles for Enhanced Oral Cancer Treatment.负载于非离子表面活性剂囊泡纳米粒中的姜黄素与顺铂联合治疗增强口腔癌疗效
Indian J Clin Biochem. 2025 Jan;40(1):59-66. doi: 10.1007/s12291-024-01279-9. Epub 2024 Nov 11.
Asian Pac J Cancer Prev. 2017 Feb 1;18(2):365-368. doi: 10.22034/APJCP.2017.18.2.365.
4
Endothelium-targeted overexpression of heat shock protein 27 ameliorates blood-brain barrier disruption after ischemic brain injury.热休克蛋白27在内皮细胞中的靶向过表达可改善缺血性脑损伤后的血脑屏障破坏。
Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):E1243-E1252. doi: 10.1073/pnas.1621174114. Epub 2017 Jan 30.
5
Intracerebroventricular Delivery as a Safe, Long-Term Route of Drug Administration.脑室内给药作为一种安全的长期给药途径。
Pediatr Neurol. 2017 Feb;67:23-35. doi: 10.1016/j.pediatrneurol.2016.10.022. Epub 2016 Nov 10.
6
Age-associated physiological and pathological changes at the blood-brain barrier: A review.血脑屏障的年龄相关生理和病理变化:综述
J Cereb Blood Flow Metab. 2017 Jan;37(1):4-24. doi: 10.1177/0271678X16679420. Epub 2016 Nov 11.
7
Introduction for Design of Nanoparticle Based Drug Delivery Systems.基于纳米颗粒的药物递送系统设计简介。
Curr Pharm Des. 2017;23(14):2108-2112. doi: 10.2174/1381612822666161025154003.
8
Progress and perspectives on targeting nanoparticles for brain drug delivery.用于脑药物递送的靶向纳米颗粒的研究进展与展望
Acta Pharm Sin B. 2016 Jul;6(4):268-86. doi: 10.1016/j.apsb.2016.05.013. Epub 2016 Jun 14.
9
Safety Evaluation of CNS Administered Biologics-Study Design, Data Interpretation, and Translation to the Clinic.中枢神经系统给药生物制品的安全性评估——研究设计、数据解读及向临床的转化
Toxicol Sci. 2016 Jul;152(1):3-9. doi: 10.1093/toxsci/kfw072.
10
In Vitro and In Vivo Evaluation of Niosomal Formulation for Controlled Delivery of Clarithromycin.克拉霉素控释非离子表面活性剂囊泡制剂的体外和体内评价
Scientifica (Cairo). 2016;2016:6492953. doi: 10.1155/2016/6492953. Epub 2016 May 16.